Skip to search.
 TSX Down 0.79% TSX Ventures Down 0.04%

Biogen Inc. (BIIB)

-NasdaqGS
252.20 Up 2.21(0.88%) 4:00PM EST
|After Hours : 251.90 Down 0.30 (0.12%) 6:20PM EST
Prev Close:249.99
Open:253.35
Bid:249.90 x 100
Ask:252.18 x 100
1y Target Est:354.94
Beta:0.512311
Earnings Date:Apr 22 - Apr 26 (Est.)
Day's Range:249.28 - 257.37
52wk Range:243.85 - 480.18
Volume:1,763,495
Avg Vol (3m):1,879,030
Market Cap:55.15B
P/E (ttm):16.44
EPS (ttm):15.34
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BIIBUp 0.88%55.15B
PFEUp 1.34%182.06B
ABTUp 0.57%55.51B

Key Statistics

Forward P/E (1 yr):12.53
P/S (ttm):5.08
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :18.63
Quarterly EPS Est (Mar-16) :4.46
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):1.43

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Biogen Inc. discovers, develops, manufactures, and delivers therapies for the treatment of neurodegenerative diseases, hematologic conditions, and autoimmune disorders. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback